Last reviewed · How we verify
Haemophilus Influenzae Acute Otitis Media
Approved treatments
- Cefradex · Bristol-Myers Squibb
- Amoxycillin · King George's Medical University
- Azo Gantanol · Pfizer
- Unasyn · Bristol-Myers Squibb
- Azo Gantrisin · Alra
- Trimethoprim · Dr Reddys Labs Sa
- Ceftin · GSK
Ceftin works by inhibiting the bacterial enzyme responsible for cell wall synthesis, ultimately leading to bacterial cell death. - Demethylchlortetracycline · Pfizer
- Sulfurine
- Amoxil · Generic (originally Beecham/GSK)
Broad-spectrum aminopenicillin that inhibits bacterial cell wall synthesis by binding penicillin-binding proteins. - E-Mycin · Generic (originally Abbott/Lilly)
- Cefzil · Teva Pharmaceuticals USA
- Meclan · Johnson And Johnson
- Zithromax · Pfizer Inc.
Macrolide antibiotic that binds the 50S ribosomal subunit, inhibiting bacterial protein synthesis with an exceptionally long tissue half-life. - Benzamycin · Pfizer
- Cedax · Burke Therap
- Vantin
- Keflex · Shionogi
- Zinacef · GSK
Zinacef works by inhibiting bacterial cell wall synthesis, ultimately leading to bacterial cell death. - Augmentin 250 · Dr Reddys Labs Inc
- Biaxin · Generic (originally Abbott/AbbVie)
Clarithromycin is a macrolide antimicrobial drug. - Suprax
Suprax works by inhibiting the bacterial enzyme 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1, disrupting bacterial cell wall synthesis. - Levaquin · Generic (originally Daiichi Sankyo/J&J)
Levofloxacin is a fluoroquinolone antibacterial agent. - Cephradin · Sohag University
- Amoxicilli · Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Haemophilus Influenzae Acute Otitis Media patent landscape — cliff calendar, originator estates, attackable patents
- Haemophilus Influenzae Acute Otitis Media treatment landscape brief
- Haemophilus Influenzae Acute Otitis Media treatment updates RSS
Frequently asked questions about Haemophilus Influenzae Acute Otitis Media
What drugs treat Haemophilus Influenzae Acute Otitis Media?
Tracked treatments include Cefradex, Amoxycillin, Azo Gantanol, Unasyn, Azo Gantrisin, Trimethoprim, Ceftin, Demethylchlortetracycline.
What is the treatment for Haemophilus Influenzae Acute Otitis Media?
Standard treatment for Haemophilus Influenzae Acute Otitis Media includes Cefradex, Amoxycillin, Azo Gantanol, Unasyn, Azo Gantrisin. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Haemophilus Influenzae Acute Otitis Media patent cliff · Haemophilus Influenzae Acute Otitis Media CI report
- Treatment: Cefradex · Bristol-Myers Squibb
- Treatment: Amoxycillin · King George's Medical University
- Treatment: Azo Gantanol · Pfizer
- Treatment: Unasyn · Bristol-Myers Squibb
- Treatment: Azo Gantrisin · Alra
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing